31 Followers on Owler

AnTolRx

develops and commercializes antigen-specific tolerogenic molecules to treat autoimmune diseases.. Read more
OverviewCompetitorsFundingNews & Insights

AnTolRx

develops and commercializes antigen-specific tolerogenic molecules to treat autoimmune diseases.. Read more
AnTolRx Chairman & CEO: Mark Carthy

Chairman & CEO

Mark Carthy

CEO Approval Rating

90/100

2014

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Pharmaceuticals
2836 NAICS listing

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$5M

News

Mar 07, 2019
in-PharmaTechnologist
AnTolRx: Pfizer licenses immune tolerance therapy for type 1 diabetes
Mar 06, 2019
pipelinereview
AnTolRx: AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes

AnTolRx Competitors

1Entelos
2Crescendo Bioscience
3True Health Group LLC
4Viela Bio
5Sagimet
6Xenetic Biosciences
7IM Therapeutics
8Oncorus
9DIARECT
10Genomic Health
Unlock 7 + competitors

Trending Companies